1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Assa-Munt, N. Jia, X. Laakkonen, P. Ruoslahti, E. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 40 2373 2378 10.1021/bi002101f 11327857 Solution structures and integrin binding activities of an RGD peptide with two isomers. 2001 US ANNU.REV.CELL DEV.BIOL. 1081-0706 12 697 715 10.1146/annurev.cellbio.12.1.697 RGD and other recognition sequences for integrins. 1996 10.2210/pdb1fuv/pdb pdb_00001fuv 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1150.311 RGD PEPTIDE ISOMER-A 1 syn polymer no no ACDCRGDCFCG ACDCRGDCFCG A polypeptide(L) n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-05-16 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession 1FUL is the solution structure of an RGD Peptide Isomer-B RCSB Y RCSB 2000-09-15 REL REL peptide was chemically synthesized sample back calculated data agree with experimental NOESY spectrum,structures with acceptable covalent geometry,structures with favorable non-bond energy,structures with the least restraint violations,structures with the lowest energy 100 19 2D NOESY DQF-COSY 1 atm 293 K distance geometry simulated annealing 8 closest to the average 2.5 mg DMSO Alex.T. Brunger refinement X-PLOR 3.851 500 Varian UNITYPLUS ALA 1 n 1 ALA 1 A CYS 2 n 2 CYS 2 A ASP 3 n 3 ASP 3 A CYS 4 n 4 CYS 4 A ARG 5 n 5 ARG 5 A GLY 6 n 6 GLY 6 A ASP 7 n 7 ASP 7 A CYS 8 n 8 CYS 8 A PHE 9 n 9 PHE 9 A CYS 10 n 10 CYS 10 A GLY 11 n 11 GLY 11 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A O O ALA PHE 1 9 2.15 1 A ARG 5 0.307 SIDE CHAIN 2 A ARG 5 0.275 SIDE CHAIN 3 A ARG 5 0.315 SIDE CHAIN 4 A ARG 5 0.233 SIDE CHAIN 5 A ARG 5 0.314 SIDE CHAIN 6 A ARG 5 0.250 SIDE CHAIN 7 A ARG 5 0.315 SIDE CHAIN 8 A ARG 5 0.264 SIDE CHAIN 9 A ARG 5 0.296 SIDE CHAIN 10 A ARG 5 0.288 SIDE CHAIN 11 A ARG 5 0.278 SIDE CHAIN 12 A ARG 5 0.300 SIDE CHAIN 13 A ARG 5 0.266 SIDE CHAIN 14 A ARG 5 0.266 SIDE CHAIN 15 A ARG 5 0.277 SIDE CHAIN 16 A ARG 5 0.318 SIDE CHAIN 17 A ARG 5 0.297 SIDE CHAIN 18 A ARG 5 0.308 SIDE CHAIN 19 A ARG 5 0.246 SIDE CHAIN 1 A ASP 3 -137.45 -57.32 1 A CYS 4 -54.79 -116.02 1 A ARG 5 -155.19 -47.25 1 A CYS 8 -90.83 56.07 2 A ASP 3 -136.70 -64.70 2 A CYS 4 -55.52 -112.75 2 A ARG 5 -152.99 -74.90 2 A CYS 8 -99.71 32.17 2 A PHE 9 -49.00 170.48 3 A ASP 3 -128.08 -62.35 3 A CYS 4 -54.64 -109.56 3 A ARG 5 -153.51 -78.08 3 A PHE 9 -46.61 172.65 4 A CYS 4 -49.16 -106.47 4 A ARG 5 -154.85 -87.70 4 A ASP 7 -134.23 -50.72 4 A PHE 9 -54.99 178.43 5 A ASP 3 -133.17 -64.63 5 A CYS 4 -52.76 -108.81 5 A ARG 5 -152.75 -77.24 5 A CYS 8 -90.47 49.50 6 A ASP 3 -136.01 -62.61 6 A CYS 4 -52.65 -115.14 6 A ARG 5 -154.72 -45.36 6 A CYS 8 -96.24 40.04 7 A ASP 3 -134.51 -66.19 7 A CYS 4 -50.61 -110.11 7 A ARG 5 -153.55 -83.17 7 A CYS 8 -85.76 41.75 8 A ASP 3 -133.83 -62.90 8 A CYS 4 -54.41 -112.84 8 A ARG 5 -154.19 -89.60 8 A ASP 7 -139.55 -49.79 8 A CYS 8 -90.31 33.51 9 A ASP 3 -136.16 -70.49 9 A CYS 4 -49.93 -111.15 9 A ARG 5 -153.37 -85.28 9 A ASP 7 -121.50 -56.24 9 A CYS 8 -82.84 37.32 10 A ASP 3 -131.30 -63.41 10 A CYS 4 -53.63 -110.73 10 A ARG 5 -153.78 -85.26 10 A ASP 7 -127.82 -52.29 10 A CYS 8 -88.86 34.35 11 A ASP 3 -126.36 -64.15 11 A CYS 4 -51.51 -110.13 11 A ARG 5 -153.72 -82.56 11 A CYS 8 -90.21 32.15 12 A ASP 3 -134.96 -65.60 12 A CYS 4 -51.34 -111.15 12 A ARG 5 -153.47 -77.90 12 A CYS 8 -86.36 48.95 13 A ASP 3 -137.22 -63.12 13 A CYS 4 -57.61 -112.81 13 A ARG 5 -152.93 -74.12 13 A PHE 9 -43.98 168.86 14 A ASP 3 -139.36 -48.46 14 A CYS 4 -60.94 -120.67 14 A ARG 5 -154.53 -80.59 14 A ASP 7 -139.40 -71.62 15 A ASP 3 -124.44 -61.11 15 A CYS 4 -54.96 -107.45 15 A ARG 5 -153.75 -76.83 15 A PHE 9 -48.60 173.35 16 A ASP 3 -131.99 -63.90 16 A CYS 4 -52.59 -110.80 16 A ARG 5 -153.54 -84.93 16 A ASP 7 -122.93 -52.30 16 A CYS 8 -88.41 33.81 17 A ASP 3 -120.98 -60.62 17 A CYS 4 -56.20 -106.90 17 A ARG 5 -153.12 -74.31 17 A PHE 9 -44.08 171.62 18 A ASP 3 -125.92 -60.67 18 A CYS 4 -55.21 -107.86 18 A ARG 5 -153.55 -77.03 18 A PHE 9 -47.10 174.39 18 A CYS 10 -94.85 49.38 19 A CYS 4 -55.39 -104.98 19 A ARG 5 -153.92 -74.66 19 A PHE 9 -47.60 174.48 SOLUTION STRUCTURE OF AN RGD PEPTIDE ISOMER-A 1 N N disulf 2.026 A CYS 2 A SG CYS 2 1_555 A CYS 10 A SG CYS 10 1_555 disulf 2.023 A CYS 4 A SG CYS 4 1_555 A CYS 8 A SG CYS 8 1_555 CELL ADHESION Double S-S bonds, type I beta-turn, CELL ADHESION 1FUV PDB 1 1FUV 1 11 1FUV 1 11 1FUV A 1 1 11 1 P 1